EIM
CNST

Essex Investment Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Essex Investment Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-66,186
Closed -$897K – 527
2019
Q1 		$897K Buy
+66,186
New +$593K 0.13% 214

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Essex Investment Management's CNST Position: Q2 2019 in Review

Essex Investment Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2019, closing a stake of 66,186 shares — an estimated $897K sold.

Essex Investment Management first reported a position in CNST in Q1 2019 and held it in 1 quarter. The position peaked at $897K in Q1 2019. 50 funds tracked by Wall St. Rank hold CNST as of Q2 2019.

  • Essex Investment Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Essex Investment Management sold 66,186 Constellation Pharmaceuticals, Inc. shares in Q2 2019, an estimated $897K.
  • Essex Investment Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
  • Essex Investment Management's Constellation Pharmaceuticals, Inc. position peaked at $897K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2019.

Based on Essex Investment Management's 13F filing for Q2 2019, filed 15 Aug 2019.